S100P and lung carcinoma: Results indicated a significant downregulation of CX3CL1, MS4A15, and GSTA1 in lung cancer cells, while EPS8L3, G6PD, KRT6A, and S100P were notably upregulated, in line with the bioinformatics analysis findings (Figure 11A–11G).